297 related articles for article (PubMed ID: 9372876)
1. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.
Tse V; Khadra M; Eisinger D; Mitterdorfer A; Boulas J; Rogers J
Urology; 1997 Nov; 50(5):690-6. PubMed ID: 9372876
[TBL] [Abstract][Full Text] [Related]
2. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
5. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
Rogers A; Ng JK; Glendinning J; Rix D
BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
[TBL] [Abstract][Full Text] [Related]
6. [Transitional carcinomas of the urinary tract: synchronous and metachronous lesions].
Arrizabalaga M; Navarro J; Mora M; Castro M; Extramiana J; Mañas A; Diez J; Paniagua P
Actas Urol Esp; 1994 Sep; 18(8):782-96. PubMed ID: 7998507
[TBL] [Abstract][Full Text] [Related]
7. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
[TBL] [Abstract][Full Text] [Related]
8. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic adenoma of the bladder: two case reports and literature review.
Nakatani T; Kuratsukuri K; Uchida J; Sugimura K; Kuroki Y; Morikawa Y
Hinyokika Kiyo; 2002 Jul; 48(7):463-6. PubMed ID: 12229190
[TBL] [Abstract][Full Text] [Related]
10. High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).
Pansadoro V; Emiliozzi P; depaula F; Scarpone P; Pizzo M; Federico G; Martini M; Pansadoro A; Sternberg CN
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):223-7. PubMed ID: 16767936
[TBL] [Abstract][Full Text] [Related]
11. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.
van der Heijden AG; Kiemeney LA; Gofrit ON; Nativ O; Sidi A; Leib Z; Colombo R; Naspro R; Pavone M; Baniel J; Hasner F; Witjes JA
Eur Urol; 2004 Jul; 46(1):65-71; discussion 71-2. PubMed ID: 15183549
[TBL] [Abstract][Full Text] [Related]
12. Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma.
Leblanc B; Duclos AJ; Bénard F; Valiquette L; Paquin JM; Lapointe S; Mauffette F; Pharand D; Faucher R; Drouin G; Perreault JP
Can J Urol; 2000 Feb; 7(1):944-8. PubMed ID: 11121250
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinoma in renal transplant recipients.
Liao CH; Chueh SC; Lai MK; Chen J
Transplant Proc; 2004 Sep; 36(7):2152-3. PubMed ID: 15518781
[TBL] [Abstract][Full Text] [Related]
14. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
[TBL] [Abstract][Full Text] [Related]
17. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic radical cystoprostatectomy: our experience in a consecutive series of 10 patients with a 3 years follow-up.
Simonato A; Gregori A; Lissiani A; Bozzola A; Galli S; Gaboardi F
Eur Urol; 2005 Jun; 47(6):785-90; discussion 790-2. PubMed ID: 15925074
[TBL] [Abstract][Full Text] [Related]
19. Intravesical bacillus Calmette-Guèrin for the treatment of superficial bladder cancer in renal transplant patients.
Palou J; Angerri O; Segarra J; Caparrós J; Guirado L; Diaz JM; Salvador-Bayarri J; Villavicencio-Mavrich H
Transplantation; 2003 Nov; 76(10):1514-6. PubMed ID: 14657696
[TBL] [Abstract][Full Text] [Related]
20. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]